NCT07320833

Brief Summary

This randomized, double-blind comparative study evaluates postoperative analgesic efficacy and motor effects of ultrasound-guided para-sartorial compartments (PASC) block versus ultrasound-guided combined femoral-sciatic nerve block in patients undergoing total knee arthroplasty. The primary endpoint is total nalbuphine rescue analgesia consumption in the first 24 postoperative hours. Secondary endpoints include pain scores (NRS), motor function using a modified Bromage scale, block performance characteristics, and complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 6, 2026

Completed
Last Updated

January 6, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 22, 2025

Last Update Submit

December 22, 2025

Conditions

Keywords

Total knee arthroplasty (TKA)Total knee replacement (TKR)Para-sartorial compartments (PASC) blockFemoral nerve blockSciatic nerve blockUltrasound-guided nerve blockRegional anesthesiaMultimodal analgesiaNalbuphine rescue analgesiaNumeric Rating Scale (NRS)Modified Bromage scale

Outcome Measures

Primary Outcomes (1)

  • Total Rescue Analgesia Requirement (Nalbuphine)

    Total dose of intravenous nalbuphine (in milligrams) administered as rescue analgesia when the Numeric Rating Scale pain score is 3 or higher, with a maximum daily dose of 20 milligrams.

    First 24 hours after surgery.

Secondary Outcomes (7)

  • Postoperative Pain Intensity (Numeric Rating Scale)

    30 minutes after admission to the post-anesthesia care unit, and 3 hours, 6 hours, 12 hours, and 24 hours after surgery.

  • Motor Block Assessment (Modified Bromage Scale)

    2 hours, 4 hours, 6 hours, 12 hours, 18 hours, and 24 hours after surgery.

  • Block Performance Time

    During block performance immediately after induction of general anesthesia.

  • Block Duration

    Up to 24 hours after surgery.

  • Postoperative Nausea

    First 24 hours after surgery.

  • +2 more secondary outcomes

Study Arms (2)

Femoral Nerve Block plus Sciatic Nerve Block

ACTIVE COMPARATOR

After induction of general anesthesia, participants receive an ultrasound-guided single-shot femoral nerve block with 15 milliliters of 0.25% bupivacaine and an ultrasound-guided single-shot popliteal sciatic nerve block with 15 milliliters of 0.25% bupivacaine. Postoperative multimodal analgesia includes intravenous acetaminophen and ketorolac. Rescue analgesia is intravenous nalbuphine 5 milligrams when the Numeric Rating Scale pain score is 3 or higher, up to 20 milligrams per day.

Procedure: Ultrasound-Guided Femoral Nerve Block plus Sciatic Nerve Block

Para-sartorial Compartments Block

EXPERIMENTAL

After induction of general anesthesia, participants receive an ultrasound-guided single-shot para-sartorial compartments block using a single needle entry point with three injections of 0.25% bupivacaine: 10 milliliters inside the femoral triangle with periarterial and subsartorial spread, 10 milliliters in the subsartorial plane at the apex of the femoral triangle between sartorius and vastus medialis muscles, and 10 milliliters in the suprasartorial compartment at the level of the intermediate femoral cutaneous nerve (total 30 milliliters). Postoperative multimodal analgesia includes intravenous acetaminophen and ketorolac. Rescue analgesia is intravenous nalbuphine 5 milligrams when the Numeric Rating Scale pain score is 3 or higher, up to 20 milligrams per day.

Procedure: Ultrasound-Guided Para-sartorial Compartments Block

Interventions

Single-shot ultrasound-guided femoral nerve block (15 milliliters of 0.25% bupivacaine) plus single-shot ultrasound-guided popliteal sciatic nerve block (15 milliliters of 0.25% bupivacaine), performed after induction of general anesthesia using sterile technique.

Femoral Nerve Block plus Sciatic Nerve Block

Single-shot ultrasound-guided para-sartorial compartments block performed after induction of general anesthesia using a single needle entry point and three injections of 0.25% bupivacaine: 10 milliliters in the femoral triangle with periarterial and subsartorial spread, 10 milliliters in the subsartorial plane at the apex of the femoral triangle, and 10 milliliters in the suprasartorial compartment at the level of the intermediate femoral cutaneous nerve (total 30 milliliters).

Para-sartorial Compartments Block

Eligibility Criteria

Age60 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60 to 70 years
  • Scheduled for elective total knee arthroplasty under general anesthesia
  • American Society of Anesthesiologists physical status class I or II
  • Provided written informed consent

You may not qualify if:

  • American Society of Anesthesiologists physical status class III or IV
  • Pre-existing neurological abnormality of the lower extremity
  • Infection near the planned block site
  • History of psychiatric illness
  • History of drug abuse
  • Known allergy to local anesthetics or any study medications (bupivacaine, acetaminophen, ketorolac, nalbuphine)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University Hospitals

Cairo, Cairo Governorate, 11511, Egypt

Location

MeSH Terms

Conditions

Osteoarthritis, KneePain, PostoperativeBites and Stings

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPoisoningChemically-Induced DisordersWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants are unaware of group assignment. Outcome data are collected by an anesthesiologist blinded to the performed block technique. The anesthesiologist performing the block is not involved in postoperative assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, double-blind, two-arm parallel-group trial comparing ultrasound-guided PASC block versus combined ultrasound-guided femoral-sciatic nerve block for postoperative analgesia and motor function after total knee arthroplasty.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident of Anesthesia, Intensive Care and Pain Management

Study Record Dates

First Submitted

December 22, 2025

First Posted

January 6, 2026

Study Start

February 1, 2023

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

January 6, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the primary and secondary outcomes (including total nalbuphine rescue dose, Numeric Rating Scale pain scores, modified Bromage motor scores, procedure time, block duration, and adverse events) will be made available to qualified researchers upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Data will be available beginning 6 months after publication of the primary manuscript and will remain available for 5 years.
Access Criteria
Requests should include a brief proposal and analysis plan. Access will be provided after review and approval by the study investigators and completion of a data use agreement. Data will be shared in a de-identified format.

Locations